What is the current size and annual growth rate of the cardiovascular catheters market?
The cardiovascular catheters market size has grown strongly in recent years. It will grow from $20.05 $ billion in 2024 to $21.87 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increase funding for research and development, growth in use of catheters in EP procedures, expansion of cardiac catheterization labs in hospitals, rise in interventional cardiology procedures, and growth in prevalence of diabetes.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $30.61 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on reducing healthcare costs, adoption of hybrid operating rooms, rise in investment by both public and private entities in cardiovascular research, increasing use of drug-eluting catheters, and development and adoption of biodegradable catheter materials. Major trends in the forecast period include integration of AI in catheter-based procedures, advanced imaging technologies, development of miniaturized catheters, adoption of robotic-assisted catheter procedures, and development of wireless, battery-free catheters.
Get Your Free Sample of The Global Cardiovascular Catheters Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19359&type=smp
Which major factors have contributed to the expansion of the cardiovascular catheters market?
The increasing prevalence of vascular heart diseases is expected to propel the growth of the cardiovascular catheter market going forward. Vascular heart diseases encompass a group of conditions affecting the blood vessels supplying the heart or within the heart itself. Changes in lifestyle habits such as diet and physical activity, an aging population, and the rising incidence of conditions such as diabetes and hypertension cause vascular heart diseases. Cardiovascular catheters help patients with vascular heart diseases by enabling minimally invasive procedures to diagnose, treat, and manage conditions such as blocked arteries and abnormal heart rhythms, leading to quicker recovery and improved outcomes. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the number of deaths caused by cardiovascular diseases reached 931,578, compared to 928,741 in 2023. Moreover, the age-adjusted death rate from cardiovascular disease also saw a modest uptick, reaching 233.3 per 100,000, marking a 4.0% increase from the previous year’s rate of 224.4 per 100,000. Therefore, the increasing prevalence of vascular heart diseases is driving the cardiovascular catheters market.
How is the cardiovascular catheters market segmented?
The cardiovascular cathetersmarket covered in this report is segmented –
1) By Product: Cardiovascular Therapeutic Catheters, Cardiovascular Diagnostic Catheters
2) By Application: Coronary Artery Diseases (CAD), Cardiac Arrhythmia, Heart Failure, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Cardiovascular Therapeutic Catheters: Angioplasty Balloons, Stent Delivery Catheters, Catheters for Ablation Therapy, Intracardiac Catheters, Thrombectomy Catheters
2) By Cardiovascular Diagnostic Catheters: Coronary Angiography Catheters, Pressure Monitoring Catheters, Electrophysiology Catheters, Intravenous Catheters for Diagnostic Imaging
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cardiovascular-catheters-global-market-report
Who are the top competitors in the cardiovascular catheters market?
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV
Which key trends are expected to influence the cardiovascular catheters market in the coming years?
Major companies operating in the cardiovascular catheters market are developing innovative products with advanced technologies, such as TRUEref technology, to enhance the accuracy and reliability of cardiac mapping. TRUEref technology enhances cardiovascular catheters by providing accurate reference signals during cardiac mapping, improving the precision of arrhythmia identification, and enabling more effective and targeted treatments. For instance, in July 2023, Biosense Webster Inc., a US-based company and a part of Johnson & Johnson MedTech, launched OPTRELL mapping catheter, a high-density diagnostic catheter with TRUEref technology. The OPTRELL mapping catheter with TRUEref technology, powered by the CARTO 3 System, offers high-definition electrophysiological mapping with 48 small electrodes, enabling clinicians to map complex cardiac arrhythmias with enhanced precision and develop more effective ablation strategies.
Which regional trends are influencing the cardiovascular catheters market, and which area dominates the industry?
Asia-Pacific was the largest region in the cardiovascular catheters market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cardiovascular Catheters Market Report 2025 Offer?
The cardiovascular catheters market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cardiovascular catheters are flexible, thin tubes inserted into blood vessels to perform diagnostic or therapeutic procedures within the heart and vascular system. They are essential in delivering treatments, monitoring blood flow, and assessing heart conditions. These catheters are a key tool in minimally invasive procedures, allowing physicians to access the heart and blood vessels without open surgery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19359
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
